• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对人腺苷 A2B 受体进行随机诱变,随后在酵母中进行生长筛选。鉴定组成型激活突变和功能获得性突变。

Random mutagenesis of the human adenosine A2B receptor followed by growth selection in yeast. Identification of constitutively active and gain of function mutations.

作者信息

Beukers Margot W, van Oppenraaij Joris, van der Hoorn Patrick P W, Blad Clara C, den Dulk Hans, Brouwer Jaap, IJzerman Adriaan P

机构信息

Division of Medicinal Chemistry, LACDR, Gorlaeus Laboratories, Leiden, The Netherlands.

出版信息

Mol Pharmacol. 2004 Mar;65(3):702-10. doi: 10.1124/mol.65.3.702.

DOI:10.1124/mol.65.3.702
PMID:14978249
Abstract

To gain insight in spontaneous as well as agonist-induced activation of the human adenosine A2B receptor, we applied a random mutagenesis approach in yeast to create a large number of receptor mutants and selected mutants of interest with a robust screening assay based on growth. The amino acid sequence of 14 mutated receptors was determined. All these mutated receptors displayed constitutive activity. In particular, single-point mutations at T42A, V54L, and F84S and a triple-point mutation at N36S, T42A, and T66A resulted in high constitutive activity. In addition, a C-terminally truncated (after Lys269) mutant, Q214L I230N V240M V250M N254Y T257S K269stop, was highly constitutively active. The T42A, V54L, and F84S mutants showed a considerable decrease, 4.9- to 6.9-fold, in the EC50 value of 5'-N-ethylcarboxamidoadenosine (NECA), an adenosine analog. Combined mutation of I242T, K269R, V284A, and H302Q, as well as F84L together with S95G, resulted in an even greater potency of NECA of 10- and 18-fold, respectively. In fact, all constitutively active mutants had an increased potency for NECA. This suggests that the wild-type (wt) human A2B receptor itself is rather silent, which may explain the low affinity of agonists for this receptor. To verify the ability of the mutant receptors to activate mammalian second messenger systems, cAMP experiments were performed in CHO cells stably expressing the wt and T42A receptors. These experiments confirmed the increased sensitivity of T42A for NECA, because the EC50 values of T42A and the wt receptor were 0.15 +/- 0.04 and 1.3 +/- 0.4 microM, respectively.

摘要

为深入了解人腺苷A2B受体的自发激活以及激动剂诱导的激活,我们在酵母中采用随机诱变方法创建了大量受体突变体,并通过基于生长的强大筛选试验筛选出感兴趣的突变体。测定了14个突变受体的氨基酸序列。所有这些突变受体均表现出组成型活性。特别是,T42A、V54L和F84S处的单点突变以及N36S、T42A和T66A处的三点突变导致了高组成型活性。此外,一个C末端截短(在Lys269之后)的突变体Q214L I230N V240M V250M N254Y T257S K269stop具有高度组成型活性。T42A、V54L和F84S突变体显示腺苷类似物5'-N-乙基羧酰胺腺苷(NECA)的EC50值显著降低,降低了4.9至6.9倍。I242T、K269R、V284A和H302Q的联合突变以及F84L与S95G的联合突变分别使NECA的效力提高了10倍和18倍。事实上,所有组成型活性突变体对NECA的效力都有所增加。这表明野生型(wt)人A2B受体本身相当不活跃,这可能解释了激动剂对该受体的低亲和力。为验证突变受体激活哺乳动物第二信使系统的能力,在稳定表达wt和T42A受体的CHO细胞中进行了cAMP实验。这些实验证实了T42A对NECA的敏感性增加,因为T42A和wt受体的EC50值分别为0.15±0.04和1.3±0.4 microM。

相似文献

1
Random mutagenesis of the human adenosine A2B receptor followed by growth selection in yeast. Identification of constitutively active and gain of function mutations.对人腺苷 A2B 受体进行随机诱变,随后在酵母中进行生长筛选。鉴定组成型激活突变和功能获得性突变。
Mol Pharmacol. 2004 Mar;65(3):702-10. doi: 10.1124/mol.65.3.702.
2
Ligand-specific binding and activation of the human adenosine A(2B) receptor.配体特异性结合和激活人腺苷 A(2B)受体。
Biochemistry. 2013 Jan 29;52(4):726-40. doi: 10.1021/bi3012065. Epub 2013 Jan 14.
3
Characterization of cancer-related somatic mutations in the adenosine A receptor.腺苷 A 受体中与癌症相关的体细胞突变的特征。
Eur J Pharmacol. 2020 Aug 5;880:173126. doi: 10.1016/j.ejphar.2020.173126. Epub 2020 Apr 26.
4
Scanning mutagenesis in a yeast system delineates the role of the NPxxY(x)(5,6)F motif and helix 8 of the adenosine A(2B) receptor in G protein coupling.在酵母系统中进行的扫描诱变确定了腺苷A(2B)受体的NPxxY(x)(5,6)F基序和螺旋8在G蛋白偶联中的作用。
Biochem Pharmacol. 2015 Jun 15;95(4):290-300. doi: 10.1016/j.bcp.2015.04.005. Epub 2015 Apr 18.
5
Domains for activation and inactivation in G protein-coupled receptors--a mutational analysis of constitutive activity of the adenosine A2B receptor.G 蛋白偶联受体的激活和失活结构域——腺苷 A2B 受体固有活性的突变分析。
Biochem Pharmacol. 2014 Nov 15;92(2):348-57. doi: 10.1016/j.bcp.2014.08.022. Epub 2014 Aug 29.
6
A functional screening of adenosine analogues at the adenosine A2B receptor: a search for potent agonists.腺苷A2B受体上腺苷类似物的功能筛选:寻找强效激动剂。
Nucleosides Nucleotides. 1998 Jun;17(6):969-85. doi: 10.1080/07328319808004215.
7
Why are A(2B) receptors low-affinity adenosine receptors? Mutation of Asn273 to Tyr increases affinity of human A(2B) receptor for 2-(1-Hexynyl)adenosine.为什么A(2B)受体是低亲和力腺苷受体?将天冬酰胺273突变为酪氨酸可增加人A(2B)受体对2-(1-己炔基)腺苷的亲和力。
Mol Pharmacol. 2000 Dec;58(6):1349-56. doi: 10.1124/mol.58.6.1349.
8
The four cysteine residues in the second extracellular loop of the human adenosine A2B receptor: role in ligand binding and receptor function.人源腺苷 A2B 受体第二细胞外环的四个半胱氨酸残基:在配体结合和受体功能中的作用。
Biochem Pharmacol. 2011 Aug 15;82(4):389-99. doi: 10.1016/j.bcp.2011.05.008. Epub 2011 May 18.
9
The second extracellular loop of GPCRs determines subtype-selectivity and controls efficacy as evidenced by loop exchange study at A2 adenosine receptors.GPCRs 的第二细胞外环决定了亚型选择性,并通过 A2 腺苷受体的环交换研究证明了其控制效力。
Biochem Pharmacol. 2013 May 1;85(9):1317-29. doi: 10.1016/j.bcp.2013.03.005. Epub 2013 Mar 13.
10
Tritium-labeled agonists as tools for studying adenosine A receptors.氚标记激动剂作为研究腺苷 A 受体的工具。
Purinergic Signal. 2018 Sep;14(3):223-233. doi: 10.1007/s11302-018-9608-5. Epub 2018 May 11.

引用本文的文献

1
Cancer-Related Somatic Mutations in Transmembrane Helices Alter Adenosine A1 Receptor Pharmacology.跨膜螺旋中与癌症相关的体细胞突变改变了腺苷 A1 受体的药理学特性。
Molecules. 2022 Jun 10;27(12):3742. doi: 10.3390/molecules27123742.
2
Molecular Effects of Auto-Antibodies on Angiotensin II Type 1 Receptor Signaling and Cell Proliferation.自身抗体对血管紧张素 II 型 1 型受体信号转导和细胞增殖的分子作用。
Int J Mol Sci. 2022 Apr 2;23(7):3984. doi: 10.3390/ijms23073984.
3
Engineering a Model Cell for Rational Tuning of GPCR Signaling.工程化模型细胞以实现 G 蛋白偶联受体信号的合理调控。
Cell. 2019 Apr 18;177(3):782-796.e27. doi: 10.1016/j.cell.2019.02.023. Epub 2019 Apr 4.
4
Differences in allosteric communication pipelines in the inactive and active states of a GPCR.G蛋白偶联受体(GPCR)非活性状态和活性状态下变构通讯途径的差异。
Biophys J. 2014 Jul 15;107(2):422-434. doi: 10.1016/j.bpj.2014.06.015.
5
Three "hotspots" important for adenosine A(2B) receptor activation: a mutational analysis of transmembrane domains 4 and 5 and the second extracellular loop.三个对腺苷 A(2B)受体激活很重要的“热点”:跨膜域 4 和 5 以及第二细胞外环的突变分析。
Purinergic Signal. 2012 Mar;8(1):23-38. doi: 10.1007/s11302-011-9251-x. Epub 2011 Aug 5.
6
The resurgence of A2B adenosine receptor signaling.A2B 腺苷受体信号传导的复苏。
Biochim Biophys Acta. 2011 May;1808(5):1329-39. doi: 10.1016/j.bbamem.2010.05.016. Epub 2010 May 28.
7
Afferent arteriolar vasodilator effect of adenosine predominantly involves adenosine A2B receptor activation.腺苷对入球小动脉的血管舒张作用主要涉及腺苷 A2B 受体的激活。
Am J Physiol Renal Physiol. 2010 Aug;299(2):F310-5. doi: 10.1152/ajprenal.00149.2010. Epub 2010 May 12.
8
Homology modelling of the human adenosine A2B receptor based on X-ray structures of bovine rhodopsin, the beta2-adrenergic receptor and the human adenosine A2A receptor.基于牛视紫红质、β2-肾上腺素能受体和人腺苷 A2A 受体的 X 射线结构对人腺苷 A2B 受体进行同源建模。
J Comput Aided Mol Des. 2009 Nov;23(11):807-28. doi: 10.1007/s10822-009-9299-7.
9
Invited Lectures : Overviews Purinergic signalling: past, present and future.特邀讲座:综述 嘌呤能信号传导:过去、现在与未来。
Purinergic Signal. 2006 May;2(1):1-324. doi: 10.1007/s11302-006-9006-2. Epub 2006 May 15.
10
Neoceptors: reengineering GPCRs to recognize tailored ligands.新型感受器:对G蛋白偶联受体进行重新设计以识别定制配体。
Trends Pharmacol Sci. 2007 Mar;28(3):111-6. doi: 10.1016/j.tips.2007.01.006. Epub 2007 Feb 5.